Ladenburg Thalmann Financial Services’s Pacific Biosciences PACB Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-700	Closed	-$2K	–	5169
2017 Q4	$2K	Hold	700	–	–	﹤0.01%	4796
2017 Q3	$4K	Hold	700	–	–	﹤0.01%	4485
2017 Q2	$2K	Hold	700	–	–	﹤0.01%	4613
2017 Q1	$4K	Hold	700	–	–	﹤0.01%	4384
2016 Q4	$3K	Hold	700	–	–	﹤0.01%	4431
2016 Q3	$6K	Hold	700	–	–	﹤0.01%	4083
2016 Q2	$5K	Buy	700 +400	+133%	+$3.65K	﹤0.01%	4140
2016 Q1	$3K	Buy	+300	New	+$2.95K	﹤0.01%	4270
2015 Q1	–	Sell	-14,000	Closed	-$110K	–	4628
2014 Q4	$110K	Buy	+14,000	New	+$89.6K	﹤0.01%	1830

Other funds holding PACB

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PACB Position: Q1 2018 in Review

Ladenburg Thalmann Financial Services sold out of Pacific Biosciences (PACB) in Q1 2018, closing a stake of 700 shares — an estimated $2K sold.

Ladenburg Thalmann Financial Services first reported a position in PACB in Q4 2014 and held it in 9 quarters. The position peaked at $110K in Q4 2014. 101 funds tracked by Wall St. Rank hold PACB as of Q1 2018.

Ladenburg Thalmann Financial Services reported no remaining Pacific Biosciences position as of Q1 2018 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 700 Pacific Biosciences shares in Q1 2018, an estimated $2K.
Ladenburg Thalmann Financial Services first reported a position in Pacific Biosciences in Q4 2014 and held it in 9 quarters.
Ladenburg Thalmann Financial Services's Pacific Biosciences position peaked at $110K in Q4 2014.
101 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2018, filed 15 May 2018.